Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration approved Pfizer's new opioid painkiller Friday that contains abuse-deterrent features.
Greenville, S.C.-based Agfa Healthcare, a medical imaging company, signed a contract with the U.S. government worth nearly $768 million, according to Mass Device.
New York-based drug giant Pfizer will buy the much sought after biotech Medivation for $14 billion.
When placing blame for high drug costs, most fingers point to the pharmaceutical companies. However, Scott Gotlieb, MD, former deputy commissioner of the Food and Drug Administration, says the regulatory agency is also to blame for high generic drug costs,…
A team of electrical engineers and computer scientists at the University of Washington (Seattle) developed a more power-efficient method for implanted medical devices to send health data to smartphones, reports The Seattle Times.
"Hospital supply chains are under increasing pressure to slash inventory levels and optimize labor in order to reduce costs. Gone are the days when they could rely on informal ordering processes to replenish inventory," says Robert Jones, director of logistics at Medline.
There is growing momentum within large corporations to develop a strong performance culture and increase individual accountability for productivity. As a result, low performers who typically maintained their rank year after year are being weeded out in favor of more…
Some retailers are charging as much as $700 for a set of EpiPens, the brand name life-saving injectors filled with epinephrine to stop an anaphylactic reaction, according to The Baltimore Sun. While patients pay different amounts depending on their out-of-pocket…
The August 17 article "Study: Amgen, Sanofi cholesterol drugs not cost effective, boost healthcare spending," highlights a flawed JAMA publication that exaggerates the costs of PCSK9 inhibitors and threatens to make it more difficult for patients to access them.
The Food and Drug Administration approved Ion Beam Applications' new super conducting accelerator for Proteus One, an intensity modulated proton therapy system used to treat patients with cancer.